Shanghai Quan Sheng Biotechnology

Shanghai Quansheng Biotechnology is a biotechnology company based in Shanghai, China, specializing in the development and production of innovative cell therapies. The company operates a GMP-compliant laboratory dedicated to the extraction, culture, and expansion of human umbilical cord mesenchymal stem cells (hUC-MSCs). Its research focus is primarily on immune-mediated and inflammatory conditions, with active preclinical programs targeting ischemic stroke, acute liver failure, and psoriasis. In addition to its internal drug development pipeline, the company provides high-purity stem cell products and experimental instruments to support academic and clinical research collaborations. Shanghai Quansheng aims to leverage its cell therapy platform to address significant unmet medical needs in regenerative medicine and immunology.